MyCelx Technologies Corp. said Tuesday it expects to report a swing to Ebitda loss for 2022 and that revenue will exceed guidance for the year.
---
SigmaRoc Raises 2022 Revenue, Underlying Ebitda Guidance on Strong Finish to Year
SigmaRoc PLC on Tuesday raised its guidance for 2022 results after it reported a strong performance in the final weeks of the year.
---
Vector Capital Sees 2022 Revenue Increase on Strong Performance
Vector Capital PLC said Tuesday that it booked strong performance in 2022, with revenue growth of 12%.
---
PayPoint Appoints Rob Harding as CFO
PayPoint PLC said Tuesday that it has appointed Rob Harding as chief financial officer.
---
Corcel's Chairman Swaps Cash Remuneration for Shares
Corcel PLC said Tuesday that Chairman James Parsons has decided to receive his remuneration for the next four months in stock of the company.
---
Cambridge Cognition 2022 Revenue Rose 25% But After-Tax Profit Fell
Cambridge Cognition Holdings PLC on Tuesday said its revenue grew 25% in 2022, beating market expectations, and that it has good visibility for 2023, but that its profit after tax fell.
Market Talk:
Synthomer Looks to Be on Right Track Despite Headwinds
1121 GMT - Synthomer's 2022 update shows the company is on track, but the macro environment backdrop remains a headwind, Peel Hunt analysts Harry Philips and Henry Carver say in a research note. The FTSE 250 chemical supplier's 2023 will be about strategic execution, particularly on GBP150 million-GBP200 million in cash savings by the end of the year, they add. For 2022, the analysts say their Ebitda estimate is GBP255 million against the company view of GBP262 million-GBP268 million. For 2023, they see GBP220 million in Ebitda. Peel Hunt has an add rating on the stock with a target price of 185 pence. (kyle.morris@dowjones.com)
Contact: London NewsPlus; paul.larkins@wsj.com
(END) Dow Jones Newswires
01-31-23 1210ET
